This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its unique structure, featuring a spirocyclic system and benzhydryl group, makes it valuable in the development of drugs targeting the central nervous system. It is particularly relevant in the creation of compounds with potential antipsychotic or antidepressant properties, as the structure can interact with neurotransmitter receptors. Additionally, it may be explored for its role in modulating biological pathways involved in inflammation or pain management, contributing to the development of novel treatments for neurological and psychiatric disorders.